Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy

Sirish Dharmapuri, Umut Özbek, Jung‐Yi Lin, +4

Cancer Medicine

Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19

Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld, +16

Thrombosis Research

The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma

Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, +36

Cancers

Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade

David J. Pinato, Takahiro Kaneko, Anwaar Saeed, +23

Cancers

Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice

David J. Pinato, Thomas U. Marron, Pallavi S. Mishra‐Kalyani, +39

European Journal of Cancer

HepatologyLandmark Clinical TrialsMedicineImmunologyClinical Trials +10

Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study

Petros Fessas, Ahmed O. Kaseb, Yinghong Wang, +24

Journal for ImmunoTherapy of Cancer

PathologyPost-registration ExperienceOncologyInternational StudyBackground Nivolumab +15

Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma

Petros Fessas, Muntaha Naeem, Matthias Pinter, +32

Liver Cancer

Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy

David J. Pinato, Ahmed O. Kaseb, Yinghong Wang, +24

Journal for ImmunoTherapy of Cancer

Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study

Thomas Talbot, Antonio D’Alessio, Matthias Pinter, +33

Liver International

Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma

Tomi Jun, Umut Özbek, Sirish Dharmapuri, +22

Therapeutic Advances in Medical Oncology